Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11530400 Process and system for obtaining botulinum neurotoxin

Patent 11530400 was granted and assigned to Allergan, Inc. on December, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

Rapid, animal protein free, chromatographic processes and systems for obtaining high potency, high yield botulinum neurotoxin for research, therapeutic and cosmetic use.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11530400 Process and system for obtaining botulinum neurotoxin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo